DA VINCI study: Change in approach to cholesterol management will be needed to reduce the implementation gap between guidelines and clinical practice in Europe.
Commentary discussing new evidence for early intervention to optimise population health, together with novel approaches that may offer solutions to the issue of poor adherence
Commentary on Quantifying atherogenic lipoproteins – pragmatic guidance from the EAS/EFLM Joint Consensus Initiative
